Rubrik (RBRK) director’s 10b5-1 sales, option exercises and RSU grant detailed
Rhea-AI Filing Summary
Rubrik, Inc. director John Wendell Thompson reported a mix of share sales, option exercises, and equity grants in Rubrik stock. On June 1, 2026, he and a related trust sold a combined 13,500 shares of Class A Common Stock in open-market transactions at weighted-average prices generally in the low-to-mid $80s per share, under a pre-arranged Rule 10b5-1 trading plan adopted on October 6, 2025.
On the same date, he exercised or converted derivatives covering 33,000 shares, including stock options with a $4.38 exercise price and Class B Common Stock convertible into Class A. After these moves, he retained direct and indirect holdings, including Class B shares that are convertible into 815,338 shares of Class A Common Stock and remaining Class A shares.
Separately, on June 3, 2026, Thompson received a grant of 3,709 restricted stock units, which will vest in four equal quarterly installments from September 15, 2026 through June 15, 2027, subject to continued service. Overall, the filing reflects a planned liquidity event and equity compensation, while maintaining a substantial continuing stake.
Positive
- None.
Negative
- None.
Insights
Planned sales, option exercises, and new RSUs look like routine portfolio and compensation activity.
Director John Wendell Thompson reported open-market sales of 13,500 Rubrik Class A shares, alongside exercises and conversions covering 33,000 shares. A footnote states the sales were executed under a Rule 10b5-1 trading plan adopted on October 6, 2025, indicating they were pre-scheduled rather than opportunistic.
He also exercised stock options at an exercise price of $4.38 and converted Class B Common Stock, while a derivative position tied to 815,338 underlying Class A shares remains indirectly held. This suggests the transactions represent partial monetization rather than an exit. The grant of 3,709 RSUs, vesting quarterly from September 15, 2026 to June 15, 2027, is standard director compensation structure.
The combination of continued large indirect holdings and ongoing equity awards points to routine governance and compensation practices. The net-sell of 13,500 shares appears modest relative to the remaining position, so the overall signal from this Form 4 is neutral for long-term investors.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 3,709 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 11,000 | $0.00 | -- |
| Exercise | Class B Common Stock | 11,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 11,000 | $0.00 | -- |
| Sale | Class A Common Stock | 100 | $79.91 | $8K |
| Sale | Class A Common Stock | 300 | $82.45 | $25K |
| Sale | Class A Common Stock | 160 | $83.49 | $13K |
| Sale | Class A Common Stock | 1,140 | $84.64 | $96K |
| Sale | Class A Common Stock | 800 | $85.87 | $69K |
| Conversion | Class A Common Stock | 11,000 | $0.00 | -- |
| Sale | Class A Common Stock | 200 | $79.77 | $16K |
| Sale | Class A Common Stock | 750 | $82.13 | $62K |
| Sale | Class A Common Stock | 991 | $82.73 | $82K |
| Sale | Class A Common Stock | 4,000 | $84.41 | $338K |
| Sale | Class A Common Stock | 3,359 | $85.30 | $287K |
| Sale | Class A Common Stock | 1,700 | $86.07 | $146K |
| holding | Class B Common Stock | -- | -- | -- |
Footnotes (1)
- This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted October 6, 2025. The shares are held of record by John and Sandra Thompson Trust, for which the Reporting Person serves as a co-trustee and shares voting and dispositive power with his spouse. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.99 to $82.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.22 to $83.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.28 to $85.15 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.31 to $86.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.62 to $79.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.41 to $82.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.45 to $83.16 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.84 to $84.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.86 to $85.82 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.86 to $86.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote. Represents the grant of restricted stock units ("RSUs") that will vest over a one-year period, in four (4) successive equal quarterly installments on each of September 15, 2026, December 15, 2026, March 15, 2027 and June 15, 2027, subject to the reporting person's continuous service with the Issuer on each such vest date. Fully vested. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date.